Extracellular phosphorylation converts pigment epithelium-derived factor from a neurotrophic to an antiangiogenic factor.

Blood
Galia Maik-RachlineRony Seger

Abstract

The pigment epithelium-derived factor (PEDF) belongs to the superfamily of serine protease inhibitors (serpin). There have been 2 distinct functions attributed to this factor, which can act either as a neurotrophic or as an antiangiogenic factor. Besides its localization in the eye, PEDF was recently reported to be present also in human plasma. We found that PEDF purified from plasma is a phosphoprotein, which is extracellularly phosphorylated by protein kinase CK2 (CK2) and to a lesser degree, intracellularly, by protein kinase A (PKA). CK2 phosphorylates PEDF on 2 main residues, Ser24 and Ser114, and PKA phosphorylates PEDF on one residue only, Ser227. The physiologic relevance of these phosphorylations was determined using phosphorylation site mutants. We found that both CK2 and PKA phosphorylations of PEDF markedly affect its physiologic function. The fully CK2 phosphorylation site mutant S24, 114E abolished PEDF neurotrophic activity but enhanced its antiangiogenic activity, while the PKA phosphorylation site mutant S227E reduced PEDF antiangiogenic activity. This is a novel role of extracellular phosphorylation that is shown here to completely change the nature of PEDF from a neutrophic to an antiangiogenic factor.

References

Jan 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·J L MallerE G Krebs
Feb 14, 1992·Biochemical and Biophysical Research Communications·K TakahashiM Tanabe
Aug 1, 1990·Analytical Biochemistry·B Korc-GrodzickiS Shaltiel
Sep 1, 1991·Experimental Eye Research·J Tombran-TinkL V Johnson
Sep 24, 1990·Biochimica Et Biophysica Acta·L A Pinna
Oct 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·B Korc-GrodzickiS Shaltiel
Aug 15, 1984·Archives of Biochemistry and Biophysics·G M Hathaway, J A Traugh
Jan 1, 1982·Methods in Enzymology·S C Strom, G Michalopoulos
Feb 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·F R SteeleJ Tombran-Tink
Dec 1, 1996·Protein Science : a Publication of the Protein Society·E StratikosS P Becerra
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·H JaaroR Seger
Jul 20, 1999·Journal of Neuropathology and Experimental Neurology·M M BilakR W Kuncl
Nov 5, 1999·Trends in Pharmacological Sciences·F A RedegeldM V Sitkovsky
Feb 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·V StellmachN Bouck
Sep 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·M SimonovicK Volz
Feb 14, 2002·Archives of Biochemistry and Biophysics·Iris SchvartzShmuel Shaltiel

❮ Previous
Next ❯

Citations

Nov 16, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·N I Fernandez-GarciaB Jimenez
Mar 15, 2013·Nature Reviews. Cancer·S Patricia Becerra, Vicente Notario
Oct 19, 2012·Molecular Human Reproduction·Dana ChuderlandRuth Shalgi
Jan 19, 2012·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Eliza Moskowitz-KassaiMichael S Goligorsky
Nov 9, 2010·American Journal of Respiratory Cell and Molecular Biology·Laszlo FarkasMartin Kolb
Apr 29, 2014·Molecular and Cellular Endocrinology·Dana ChuderlandRuth Shalgi
Jun 16, 2012·Journal of Biomedicine & Biotechnology·P SubramanianS P Becerra
Jul 23, 2014·Reproduction : the Official Journal of the Society for the Study of Fertility·Dana ChuderlandRuth Shalgi
Jun 13, 2012·Journal of Biomedicine & Biotechnology·Vijay Chandolu, Crispin R Dass
Nov 20, 2009·Expert Opinion on Therapeutic Targets·Matthew L BroadheadPeter F M Choong
May 7, 2013·Expert Opinion on Drug Discovery·Susan E CrawordOlga V Volpert
Feb 18, 2011·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Jean-Daniel AbrahamChantal Mourton-Gilles
Sep 29, 2009·Trends in Molecular Medicine·Matthew L BroadheadPeter F M Choong
Jun 5, 2007·Journal of Biotechnology·Angela Chui Ping ChinAndre Boon Hwa Choo
Dec 8, 2006·Proteomics·Karlheinz MannMatthias Mann
Jun 24, 2014·Acta Ophthalmologica·Anne Louise Askou
May 3, 2006·The American Journal of Pathology·Andrei A KramerovAlexander V Ljubimov
Aug 16, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Jin-Peng HeJie-Xiong Feng
Mar 17, 2010·Journal of Proteomics·A M Rodríguez-PiñeiroM Páez de la Cadena
Jan 5, 2007·The Journal of Biological Chemistry·Zuzana ValnickovaJan J Enghild
May 1, 2021·International Journal of Molecular Sciences·Filipa Lopes-CoelhoJacinta Serpa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.